menu
    • menu

    Company profile for Pharmanoid

    Inke SA-PSE
    News
    Inke Acquires Pharmanoid For Ophthalmic High Potent API Assets

    17 Dec 2025

    // PRESS RELEASE

    Mankind Pharma Targets Early Semaglutide Launch

    16 Mar 2026

    // ECONOMICTIMES

    Zydus Gets USFDA Nod For Cevimeline HCL Capsules

    16 Mar 2026

    // INDPHARMAPOST

    DATA COMPILATION
    #PharmaFlow

    RM

    Contact Supplier

    Website

    ChemTides

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/fda-s-december-2025-opoe-list-features-784-prescription-drugs-73-otc-drugs

    EVENTS

    DIGITAL CONTENT

    PharmaCompass
    Related CompaniesRelated Companies

    About

    A plant dedicated to the development and manufacture of High Potency Active Pharmaceutical Ingredients (HPAPIs) including various Prostaglandins for ophthalmological use.
    The installations have full cGMP certifications, ensuring safe handling and containment of the HPAPIs, which provides a secure environment for the employees and the products manufactured.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    PharmanoidSpain_new Flag
    Country
    Country
    Spain
    Address
    Address
    C/Tramontana, 3, Pol. Ind La Carrerada, Finca 3
    Telephone
    Telephone
    +34 938992973
    Client Email
    Email
    sales@gentec.es
    Client Website
    Website
    https://www.gentec.es/empresas-del-grupo/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    ChemTides

    Not Confirmed

    envelop Contact Supplier

    ChemTides

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    NEWS #PharmaBuzz

    read-more
    read-more
    Inke Acquires Pharmanoid For Ophthalmic High Potent API Assets
    Inke Acquires Pharmanoid For Ophthalmic High Potent API Assets

    17 Dec 2025

    // PRESS RELEASE

    https://www.inke.es/news/inke-acquires-pharmanoid-a-highly-potent-api-manufacturing-site-specializing-in-ophthalmology/

    PRESS RELEASE
    17 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search